AEON Biopharma Inc.
(AEON) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.21
-1.79%
Pre-market Jan 08, 2025, 06:03 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY22 | FY21 | FY20 | FY19 |
Revenue | n/a | n/a | 2.52M | 3.36M |
Cost of Revenue | n/a | n/a | n/a | 1K |
Gross Profit | n/a | n/a | 2.52M | 3.36M |
Operating Income | -48.43M | -65.85M | -16.39M | -53.97M |
Interest Income | n/a | n/a | n/a | 720.00K |
Pretax Income | -52.56M | -55.64M | -32.91M | 145.67M |
Net Income | -52.56M | -55.64M | -32.91M | 172.92M |
Selling & General & Admin | 13.68M | 11.15M | 11.59M | 46.04M |
Research & Development | 34.75M | 25.73M | 7.32M | 4.81M |
Other Expenses | n/a | 10.21M | -5.61M | -10.75M |
Operating Expenses | 48.43M | 36.88M | 18.91M | 51.73M |
Interest Expense | n/a | n/a | 15.00K | 7.47M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 48.43M | 36.88M | 18.91M | 51.73M |
Income Tax | -160.49K | 28.97M | 15.00K | -14.64M |
Shares Outstanding (Basic) | n/a | 22.00M | 14.80M | 14.80M |
Shares Outstanding (Diluted) | n/a | 22.00M | 14.80M | 14.80M |
EPS (Basic) | n/a | -2.53 | -2.22 | 11.69 |
EPS (Diluted) | n/a | -2.53 | -2.22 | 11.69 |
EBITDA | -48.36M | -7.91M | -22.14M | -50.41M |
Depreciation & Amortization | 68.00K | 3.00K | -5.75M | 1.26M |